No photo of Patrizia Pugliese

Patrizia Pugliese


Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Autoantibodies specific to estrogen receptor alpha act as estrogen agonists and their levels correlate with breast cancer cell proliferation

Maselli, A., Capoccia, S., Pugliese, P., Raggi, C., Cirulli, F., Fabi, A., Malorni, W., Pierdominici, M. & Ortona, E., Feb 2016, In : OncoImmunology. 5, 2, p. e1074375

Research output: Contribution to journalArticle

Rehabilitation pathways in adult brain tumor patients in the first 12 months of disease. A retrospective analysis of services utilization in 719 patients

Pace, A., Villani, V., Parisi, C., Di Felice, S., Lamaro, M., Falcicchio, C., Bonucci, A., Pugliese, P., Di Napoli, A. & Di Lallo, D., Jul 15 2016, (Accepted/In press) In : Supportive Care in Cancer. p. 1-6 6 p.

Research output: Contribution to journalArticle

Sarcoma patients' quality of life from diagnosis to yearly follow-up: Experience from an Italian tertiary care center

Maggi, G., Terrenato, I., Giacomelli, L., Zoccali, C., Condoleo, M. F., Falcicchio, C., Baldi, J., Vari, S., Ferraresi, V., Biagini, R. & Pugliese, P., Jan 1 2019, In : Future Oncology. 15, 27, p. 3125-3134 10 p.

Research output: Contribution to journalArticle

The course of cancer related fatigue up to ten years in early breast cancer patients: What impact in clinical practice?

Fabi, A., Falcicchio, C., Giannarelli, D., Maggi, G., Cognetti, F. & Pugliese, P., Aug 1 2017, In : Breast. 34, p. 44-52 9 p.

Research output: Contribution to journalArticle

The unmet need for oncofertility preservation in women: Results of a survey by different oncological specialists in Lazio, Italy

Fabi, A., Lanzetta, G., Vizza, E., Corsi, D., Moscetti, L., Spinelli, G., Mentuccia, L., Lalle, M., Perrone, M., Baiocco, L., Falcicchio, C., Milani, A., Giannarelli, D., Cognetti, F. & Pugliese, P., Dec 2019, In : Current Problems in Cancer. 43, 6, 100479.

Research output: Contribution to journalArticle

Trends in the choice of first line treatment for hormone - responsive (HR+), human epidermal growth factor receptor - 2 negative (HER2-) metastatic breast cancer (MBC) patients (pts): results of a multicentric Italian observational study

D' Alonzo, A., Bighin, C., Puglisi, F., Gerratana, L., De Laurentis, M., Fontana, A., Pugliese, P., Ferzi, A., Montemurro, F., Arpino, G., Poggio, F., Vaglica, M., Dellepiane, C., Blondeaux, E., Benedetta, C., Cognetti, F., Garrone, O., Turletti, A., Pastorino, S. & Del Mastro, L., Oct 1 2017, In : Annals of oncology : official journal of the European Society for Medical Oncology. 28, p. vi25

Research output: Contribution to journalArticle

Open Access